Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY2 | P41231 | 13/20 | 0.58 |
| ▸ | P2RY4 | P51582 | 9/20 | 0.58 |
| ▸ | P2RY6 | Q15077 | 11/20 | 0.56 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.54 |
| ▸ | POLA1 | P09884 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL38662148 | 0.98 | P2RY6 (0.56) | P2RY2P2RY4P2RY6P2RY14 | |
| SCHEMBL2011098 | 0.89 | P2RY2 (0.62) | P2RY2P2RY4P2RY6POLA1 | |
| SCHEMBL31252548 | 0.89 | P2RY14 (0.54) | P2RY2P2RY4P2RY6P2RY14POLA1 | |
| SCHEMBL30423444 | 0.87 | P2RY2 (0.60) | P2RY2P2RY4P2RY6P2RY14POLA1 | |
| SCHEMBL18486642 | 0.87 | P2RY6 (0.59) | P2RY2P2RY4P2RY6P2RY14POLA1 | |
| SCHEMBL8437841 | 0.85 | P2RY2 (0.59) | P2RY2P2RY4P2RY6POLA1 | |
| SCHEMBL607049 | 0.85 | POLA1 (0.60) | P2RY2P2RY4P2RY6POLA1 | |
| SCHEMBL30367562 | 0.85 | P2RY2 (0.57) | P2RY2P2RY4P2RY6P2RY14POLA1 | |
| SCHEMBL8440926 | 0.84 | P2RY2 (0.56) | P2RY2P2RY4P2RY6POLA1 | |
| SCHEMBL6445415 | 0.84 | P2RY6 (0.52) | P2RY2P2RY4P2RY6P2RY14POLA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121380249-B | Method for preparing 2' -methoxy-uridine triphosphate | 泰兴合全药业有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-121380249-B | Method for preparing 2' -methoxy-uridine triphosphate | 泰兴合全药业有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-121380249-B | Method for preparing 2' -methoxy-uridine triphosphate | 泰兴合全药业有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-121380249-A | Method for preparing 2' -methoxy-uridine triphosphate | 泰兴合全药业有限公司 | 2026-01-23 | — | — | CN | disclosed |
| WO-2025096982-A1 | TRANS AMPLIFYING RNAS COMPRISING CHEMICALLY MODIFIED NUCLEOBASES | AMPLITUDE THERAPEUTICS, INC. (US) | 2025-05-08 | — | — | WO | disclosed |
| CN-117247932-A | Method for improving utilization rate of cap analogues in-vitro transcription | 南京诺唯赞生物科技股份有限公司 | 2023-12-19 | — | — | CN | disclosed |